FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in Germany

Biotech startups that raised Series A in Germany

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in Germany
One-time CSV
  • 58 funded companies, 27 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~germany.csv58 rows × 18 columns
CompanyCityLast roundAmountDate
Cellbox SolutionsCologneSeries A$1.7M2026-10-20
mbiomicsMunichSeries A$12.0M2026-04-28
KupandoSchönefeldSeries A$11.5M2026-03-18
MindpeakHamburgSeries A$15.3M2024-09-30
PL BioScienceAachenSeries A$8.5M2024-08-08
SciRhomMartinsriedSeries A$68.1M2024-07-09
InsempraPlaneggSeries A$20.0M2024-05-07
traceless materialsHamburgSeries A$38.8M2023-09-25

8 rows of the CSV in 5 of its 18 columns.

58
Startups
$489.2M
Total raised
6
Funded in the last 12 months
$70.2M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

12 of 58
12 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne Series A $1.7M 2026-10-20 $15.3M European Innovation Council, Fraunhofer Venture, CK Venture Capital 11 to 50 2017
mbiomics mbiomics is a biotechnology company. Biotech Munich Series A $12.0M 2026-04-28 $26.1M HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital 11 to 50 2020
Kupando Kupando is a biopharmaceutical company developing agonists that stimulate innate immunity. Biotech Schönefeld Series A $11.5M 2026-03-18 $24.0M HTGF (High-Tech Gruenderfonds), Brandenburg Kapital, Remiges Ventures +2 1 to 10 2018
Mindpeak Mindpeak develops AI-based diagnostic software that detects, quantifies, and classifies cancer. Artificial intelligence Hamburg Series A $15.3M 2024-09-30 European Innovation Council, EIC Accelerator, Nina Capital +2 11 to 50 2018
PL BioScience PL BioScience delivers 2D and 3D cell culture solutions based on human Platelet Lysate. Biotech Aachen Series A $8.5M 2024-08-08 $13.0M TechVision Fund, better ventures, Brightlands Venture Partners +1 11 to 50 2015
traceless materials traceless materials develops circular bioeconomy alternatives to conventional plastics and bioplastics. Biotech Hamburg Series A $38.8M 2023-09-25 HTGF (High-Tech Gruenderfonds), European Innovation Council, Planet A Ventures +2 51 to 100 2020
anvajo anvajo is a Dresden-based company that develops, manufactures and sells liquid analysis solutions. Biotech Dresden Series A $17.3M 2022-10-19 Think.Health, Die Brückenköpfe, Johnsonville Ventures 51 to 100 2016
GeneQuine Biotherapeutics GeneQuine Biotherapeutics develops gene therapy for treating osteoarthritis. Biotech Hamburg Series A $6.6M 2021-02-15 HTGF (High-Tech Gruenderfonds), IFB Innovationsstarter, Meusinvest (Noshaq) 1 to 10 2011
Cytena Cytena develops single-cell printing technology for cell research and professional diagnostics. Biotech Freiburg Series A $3.4M 2019-03-26 $4.6M HTGF (High-Tech Gruenderfonds), VentureOut 101 to 250 2014
Luxendo Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments. Biotech Heidelberg Series A $8.5M 2017-01-12 EQT Life Sciences, EMBL Ventures, LSP BioVentures 11 to 50 2015
ELARA Pharmaceuticals ELARA Pharmaceuticals provides research and development services for new anti-cancer drugs. Biotech Heidelberg Series A $6.9M 2009-11-26 KfW, EMBL Ventures, WFT 11 to 50 2006
BioPheresis BioPheresis Technologies, based in Heidelberg, Germany, develops a blood treatment system aimed at curing cancer. Biotech Heidelberg Series A $8.0M 2005-05-13 firstVentury Equity, SLS Venture 1 to 10 2003

Table 1. Biotech startups that raised Series A in Germany: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 58.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 mbiomics mbiomics is a biotechnology company. Biotech Munich Series A $12.0M 2026-04-28 $26.1M HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital 11 to 50 2020
2 Kupando Kupando is a biopharmaceutical company developing agonists that stimulate innate immunity. Biotech Schönefeld Series A $11.5M 2026-03-18 $24.0M HTGF (High-Tech Gruenderfonds), Brandenburg Kapital, Remiges Ventures +2 1 to 10 2018
3 Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne Series A $1.7M 2026-10-20 $15.3M European Innovation Council, Fraunhofer Venture, CK Venture Capital 11 to 50 2017

Table 2. Biotech startups that raised Series A in Germany: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 22 38% 2 mbiomics, Kupando
2 KfW Government investment office Frankfurt, Germany 6 10%
3 Bayern Kapital Venture capital firm Landshut, Germany 5 9% 1 mbiomics
4 Fraunhofer Venture Venture capital firm Munich, Germany 3 5% 1 Cellbox Solutions
5 European Innovation Council Startup accelerator Brussels, Belgium 3 5% 1 Cellbox Solutions
6 EMBL Ventures Venture capital firm Heidelberg, Germany 3 5%
7 MIG Capital Venture capital firm Munich, Germany 2 3% 1 mbiomics
8 Andera Partners Private equity firm Paris, France 2 3%
9 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 2 3%
10 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 2 3%
11 Seventure Partners Venture capital firm Paris, France 2 3%
12 LSP BioVentures Venture capital firm Cambridge, United States 2 3%
13 LBBW VC Corporate venture arm Stuttgart, Germany 2 3%
14 IFB Innovationsstarter Venture capital firm Hamburg, Germany 2 3%
15 Cascara Ventures Venture capital firm Brussels, Belgium 2 3%

Table 3. Biotech startups that raised Series A in Germany: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 43 74% $445.1M
Software 4 7% $19.0M
Artificial intelligence 2 3% $19.0M
Education 1 2%
Hardware 1 2%

Table 4. Biotech startups that raised Series A in Germany by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 58 100% $9.6M

Table 5. Biotech startups that raised Series A in Germany by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Munich 5 9%
Hamburg 5 9%
Berlin 5 9%
Martinsried 4 7%
Heidelberg 3 5%
Tübingen 2 3%
Freiburg 2 3%
Planegg 2 3%
Eßlingen 2 3%
Cologne 1 2%
Schönefeld 1 2%
Würzburg 1 2%

Table 6. Biotech startups that raised Series A in Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 17% $1.7M
September 2026 1 17% $13.7M
April 2026 1 17% $12.0M
March 2026 2 33% $22.8M
December 2025 1 17% $20.0M

Table 7. Biotech startups that raised Series A in Germany: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 5 9% $50.2M
2025 2 3% $20.0M
2024 6 10% $115.7M
2023 2 3% $63.7M
2022 2 3% $17.3M
2021 6 10% $183.3M

Table 8. Biotech startups that raised Series A in Germany by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 7 12%
2015 to 2019 16 28%
2010 to 2014 19 33%
Before 2010 15 26%

Table 9. Biotech startups that raised Series A in Germany by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 25 44%
11 to 50 26 46%
51 to 100 3 5%
101 to 250 1 2%
501 to 1,000 2 4%

Table 10. Biotech startups that raised Series A in Germany by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Germany whose last round is Series A are on the list?
58, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 58 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in Germany: 58 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Germany

Other sectors that raised Series A in Germany

Cite: FundingWatcher, 58 biotech companies in Germany whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/germany/